study,condition_arm1,condition_arm2,multi_arm1,multi_arm2,outcome_type,instrument,rating,instrument_symptom,primary_instrument,cov_time_point,time,time_weeks,time_days,primary_timepoint,post_crossover,n_arm1,mean_arm1,sd_arm1,n_arm2,mean_arm2,sd_arm2,n_change_arm1,mean_change_arm1,sd_change_arm1,n_change_arm2,mean_change_arm2,sd_change_arm2,event_arm1,totaln_arm1,event_arm2,totaln_arm2,baseline_m_arm1,baseline_sd_arm1,baseline_n_arm1,baseline_m_arm2,baseline_sd_arm2,baseline_n_arm2,rob_rand,rob_dev,rob_miss,rob_meas,rob_sel,rob,year,drug_arm1,drug_arm2,dose_arm1,dose_arm2,name_arm1,name_arm2,n_dosing_sessions,mean_age,percent_women,diagnosis,target_group,design,blinding,doi,registration_number,.id,.g,.g_se,.log_rr,.log_rr_se,.event_arm1,.event_arm2,.totaln_arm1,.totaln_arm2
Rosenblat 2024,psil,wl,NA,NA,change,madrs,clinician,depression,1,Post-first dose 1,Day 1,0.14,1,0,0,NA,NA,NA,NA,NA,NA,16,-13.277,6.3,14,-1.064,6.207409604657969,NA,NA,NA,NA,33,3.9,16,27.6,6.6,15,Some concerns,Low,Low,High,Low,High,2024,psilocybin,waitlist,25 mg,NA,immediate group,delayed group,1,44.126666666666665,39.13333333333333,trd,NA,crossover,open-label,10.1016/j.medj.2024.01.005,NCT05029466,Rosenblat2024_change_madrs_Day1_0.14_clinician_psil_wl_NA_NA,-1.8990847527256967,0.44432312524880285,NA,NA,NA,NA,NA,NA
Rosenblat 2024,psil,wl,NA,NA,change,madrs,clinician,depression,1,Post-first dose 2,Day 7,1,7,0,0,NA,NA,NA,NA,NA,NA,16,-11.319,7.828,14,-3.021,7.483314773547883,NA,NA,NA,NA,33,3.9,16,27.6,6.6,15,Some concerns,Low,Low,High,Low,High,2024,psilocybin,waitlist,25 mg,NA,immediate group,delayed group,1,44.126666666666665,39.13333333333333,trd,NA,crossover,open-label,10.1016/j.medj.2024.01.005,NCT05029466,Rosenblat2024_change_madrs_Day7_1.00_clinician_psil_wl_NA_NA,-1.0526520330118896,0.39171004114554203,NA,NA,NA,NA,NA,NA
Rosenblat 2024,psil,wl,NA,NA,change,madrs,clinician,depression,1,Post-first dose 3,Day 14,2,14,1,0,NA,NA,NA,NA,NA,NA,16,-9.6,7.6,14,-3,3.3674916480965473,NA,NA,NA,NA,33,3.9,16,27.6,6.6,15,Some concerns,Low,Low,High,Low,High,2024,psilocybin,waitlist,25 mg,NA,immediate group,delayed group,1,44.126666666666665,39.13333333333333,trd,NA,crossover,open-label,10.1016/j.medj.2024.01.005,NCT05029466,Rosenblat2024_change_madrs_Day14_2.00_clinician_psil_wl_NA_NA,-1.067193817677443,0.39240217639232955,NA,NA,NA,NA,NA,NA
Rosenblat 2024,psil,wl,NA,NA,msd,madrs,clinician,depression,1,Post-first dose 3,Day 14,2,14,1,0,16,18,12.227,14,23.44,8.695,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,3.9,16,27.6,6.6,15,Some concerns,Low,Low,High,Low,High,2024,psilocybin,waitlist,25 mg,NA,immediate group,delayed group,1,44.126666666666665,39.13333333333333,trd,NA,crossover,open-label,10.1016/j.medj.2024.01.005,NCT05029466,Rosenblat2024_msd_madrs_Day14_2.00_clinician_psil_wl_NA_NA,-0.493164108340404,0.3717666046361513,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,51,-2.7,5.101020306102035,53,-2.7,5.200078492343227,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_madrs_Day2_0.29_clinician_psil_ncn_NA_NA,0,0.19615240927798158,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,madrs,clinician,depression,1,Post-first dose 2,Day 8,1.14,8,0,NA,NA,NA,NA,NA,NA,NA,51,-17.8,11.841654282022589,53,-5.8,12.071610785796777,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_madrs_Day8_1.14_clinician_psil_ncn_NA_NA,-0.995995497988749,0.20812526490004116,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,madrs,clinician,depression,1,Post-first dose 3,Day 15,2.14,15,0,NA,NA,NA,NA,NA,NA,NA,51,-18,12.02383357866909,53,-6.9,12.628762052833554,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_madrs_Day15_2.14_clinician_psil_ncn_NA_NA,-0.8931776325130497,0.20583574904796045,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,madrs,clinician,depression,1,Post-first dose 4,Day 29,4.14,29,0,NA,NA,NA,NA,NA,NA,NA,51,-19.2,12.388192171962087,53,-5.5,13.000196230858068,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_madrs_Day29_4.14_clinician_psil_ncn_NA_NA,-1.0704618234165175,0.20992133968972562,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,madrs,clinician,depression,1,Post-first dose 5,Day 43,6.14,43,1,NA,NA,NA,NA,NA,NA,NA,51,-19.1,13.116909358548092,53,-6.8,13.7430645869071,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_madrs_Day43_6.14_clinician_psil_ncn_NA_NA,-0.908448235718669,0.20616157761368273,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,smdds,self-report,depression,0,Post-first dose 2,Day 8,1.14,8,0,NA,NA,NA,NA,NA,NA,NA,51,-21.1,14.3921644350736,48,-9.6,14.31593014419174,NA,NA,NA,NA,43.2,8.7,51,44.3,5.9,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_smdds_Day8_1.14_self-report_psil_ncn_NA_NA,-0.7948890801319491,0.20900332014933648,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,change,smdds,self-report,depression,0,Post-first dose 5,Day 43,6.14,43,1,NA,NA,NA,NA,NA,NA,NA,50,-21.8,14.791519402371655,42,-10.8,14.383276550037852,NA,NA,NA,NA,43.2,8.7,51,44.3,5.9,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_change_smdds_Day43_6.14_self-report_psil_ncn_NA_NA,-0.7467727809861876,0.21654476009846524,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,msd,madrs,clinician,depression,1,Post-first dose 5,Day 43,6.14,43,1,NA,50,16.1,13,44,27.3,12.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_msd_madrs_Day43_6.14_clinician_psil_ncn_NA_NA,-0.8699719404311148,0.21637862585958514,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,response,madrs,clinician,depression,1,Post-first dose 2,Day 8,1.14,8,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27,51,5,50,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_response_madrs_Day8_1.14_clinician_psil_ncn_NA_NA,-1.2666369401123707,0.30244092482738477,1.6665963262740489,0.4443300506377913,27,5,51,50
Raison 2023,psil,ncn,NA,NA,response,madrs,clinician,depression,1,Post-first dose 3,Day 15,2.14,15,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25,50,8,45,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_response_madrs_Day15_2.14_clinician_psil_ncn_NA_NA,-0.8375195707718613,0.26557062911054985,1.0340737675305385,0.3503966006938107,25,8,50,45
Raison 2023,psil,ncn,NA,NA,response,madrs,clinician,depression,1,Post-first dose 4,Day 29,4.14,29,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,49,7,44,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_response_madrs_Day29_4.14_clinician_psil_ncn_NA_NA,-0.9774159609753671,0.2766682271082269,1.2045557247738035,0.37173007051636603,26,7,49,44
Raison 2023,psil,ncn,NA,NA,response,madrs,clinician,depression,1,Post-first dose 5,Day 43,6.14,43,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,29,50,9,44,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_response_madrs_Day43_6.14_clinician_psil_ncn_NA_NA,-0.9191515929756765,0.2596427494203533,1.0422378811403696,0.32072822919806737,29,9,50,44
Raison 2023,psil,ncn,NA,NA,response,madrs,clinician,depression,1,Follow-up 1,Days 8-43 Sustained Response,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,48,5,44,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_response_madrs_Days8-43SustainedResponse_NA_clinician_psil_ncn_NA_NA,-0.939077329599338,0.3076372312311146,1.2992829841302609,0.45435602113254087,20,5,48,44
Raison 2023,psil,ncn,NA,NA,remission,madrs,clinician,depression,1,Post-first dose 2,Day 8,1.14,8,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,51,4,50,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_remission_madrs_Day8_1.14_clinician_psil_ncn_NA_NA,-1.00466752808607,0.32969178280315536,1.4842747694800944,0.5157011852015668,18,4,51,50
Raison 2023,psil,ncn,NA,NA,remission,madrs,clinician,depression,1,Post-first dose 3,Day 15,2.14,15,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,50,6,45,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_remission_madrs_Day15_2.14_clinician_psil_ncn_NA_NA,-0.8018967943262487,0.28945608463981215,1.0986122886681098,0.4176654695380556,20,6,50,45
Raison 2023,psil,ncn,NA,NA,remission,madrs,clinician,depression,1,Post-first dose 4,Day 29,4.14,29,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,49,5,44,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_remission_madrs_Day29_4.14_clinician_psil_ncn_NA_NA,-0.8259043293777771,0.30867262134080553,1.173303181269699,0.4608905722218417,18,5,49,44
Raison 2023,psil,ncn,NA,NA,remission,madrs,clinician,depression,1,Post-first dose 5,Day 43,6.14,43,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22,50,5,44,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_remission_madrs_Day43_6.14_clinician_psil_ncn_NA_NA,-0.9913675471035976,0.305383387785473,1.3537711694143306,0.45025245443781065,22,5,50,44
Raison 2023,psil,ncn,NA,NA,remission,madrs,clinician,depression,1,Follow-up 1,Days 8-43 Sustained Response,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,48,4,44,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_remission_madrs_Days8-43SustainedResponse_NA_clinician_psil_ncn_NA_NA,-0.6582380464968659,0.34258386474804664,1.0116009116784799,0.538305421923955,12,4,48,44
vonRotz 2023,psil,pcb,NA,NA,msd,bdi,self-report,depression,0,Pre-first dose 1,Day -1,0.14,1,0,NA,26,25.695,6.317685177341461,26,24.798,10.019573344209824,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_bdi_Day-1_0.14_self-report_psil_pcb_NA_NA,0.10548091002400753,0.2775488423344834,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,bdi,self-report,depression,0,DOSE 1,Day 0,0,0,0,NA,26,12.242,7.189617514165826,26,20.191,10.891505681034188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_bdi_Day0_0.00_self-report_psil_pcb_NA_NA,-0.8484053684553392,0.28992695928635376,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,bdi,self-report,depression,0,Post-first dose 1,Day 2,0.29,2,0,NA,26,11.823,8.933482187814558,26,22.293,11.768537037372148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_bdi_Day2_0.29_self-report_psil_pcb_NA_NA,-0.9870343526488966,0.2942442835023942,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,bdi,self-report,depression,0,Post-first dose 2,Day 8,1.14,8,0,NA,26,13.584,11.549279198287657,26,21.148,11.549279198287657,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_bdi_Day8_1.14_self-report_psil_pcb_NA_NA,-0.6450592908300974,0.28468837167440175,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,bdi,self-report,depression,0,Post-first dose 3,Day 14,2,14,1,NA,26,13.379,10.23883118329431,26,20.729,11.330021359203169,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_bdi_Day14_2.00_self-report_psil_pcb_NA_NA,-0.6704065065763803,0.2852682390799863,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,madrs,clinician,depression,1,Pre-first dose 1,Day -1,0.14,1,0,NA,26,23.534,4.186295020659676,26,24.948,7.444568489845465,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_madrs_Day-1_0.14_clinician_psil_pcb_NA_NA,-0.23060285431836317,0.27829871235087944,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,madrs,clinician,depression,1,DOSE 1,Day 0,0,0,0,NA,26,11.727,7.21511261173379,26,21.034,9.535166490418508,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_madrs_Day0_0.00_clinician_psil_pcb_NA_NA,-1.0841621390940999,0.2976133394129226,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,26,9.775,7.908579265582408,26,20.632,11.166852734768195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_madrs_Day2_0.29_clinician_psil_pcb_NA_NA,-1.105156070165739,0.2983777444924802,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,madrs,clinician,depression,1,Post-first dose 2,Day 8,1.14,8,0,NA,26,12.065,8.836600817056295,26,19.957,10.468287061405986,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_madrs_Day8_1.14_clinician_psil_pcb_NA_NA,-0.8024297251550494,0.2886266442784122,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,msd,madrs,clinician,depression,1,Post-first dose 3,Day 14,2,14,1,NA,26,11.162,9.769721388043775,26,20.696,10.23883118329431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_msd_madrs_Day14_2.00_clinician_psil_pcb_NA_NA,-0.9383678823109886,0.29266178469418314,NA,NA,NA,NA,NA,NA
vonRotz 2023,psil,pcb,NA,NA,response,madrs,clinician,depression,1,Post-first dose 3,Day 14,2,14,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,26,4,26,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_response_madrs_Day14_2.00_clinician_psil_pcb_NA_NA,-1.0941274086066806,0.37108583856923427,1.3217558399823193,0.4896361809993107,15,4,26,26
vonRotz 2023,psil,pcb,NA,NA,remission,madrs,clinician,depression,1,Post-first dose 3,Day 14,2,14,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,26,3,26,24.118,5.114316572133562,26,24.528,6.746002816483253,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_remission_madrs_Day14_2.00_clinician_psil_pcb_NA_NA,-1.189768839554913,0.40196886486895805,1.5404450409471488,0.5725721158411645,14,3,26,26
vonRotz 2023,psil,pcb,NA,NA,response,bdi,self-report,depression,0,Post-first dose 3,Day 14,2,14,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,26,3,26,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_response_bdi_Day14_2.00_self-report_psil_pcb_NA_NA,-1.189768839554913,0.40196886486895805,1.5404450409471488,0.5725721158411645,14,3,26,26
vonRotz 2023,psil,pcb,NA,NA,remission,bdi,self-report,depression,0,Post-first dose 3,Day 14,2,14,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,26,3,26,26.541,6.317685177341461,26,25.9,10.024672363723417,26,Low,Low,Low,Some concerns,Low,Some concerns,2023,psilocybin,mannitol,0.215 mg/kg,NA,psilocybin group,placebo group,1,36.75,63.45,dep,NA,parallel,double-blind,10.1016/j.eclinm.2022.101809,NCT03715127,vonRotz2023_remission_bdi_Day14_2.00_self-report_psil_pcb_NA_NA,-1.0223558354203863,0.40196886486895805,1.3862943611198906,0.5828752780343234,12,3,26,26
Goodwin 2022,psil,psil,25 mg,10 mg,change,qids-sr,self-report,depression,0,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,79,-6.3,5.895230991076665,75,-5.2,5.964970893413226,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_qids-sr_Week3_3.00_self-report_psil_psil_25mg_10mg,-0.18460291306012985,0.16156517768882575,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,qids-sr,self-report,depression,0,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,79,-6.3,5.895230991076665,79,-3.6,6.121970644579615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_qids-sr_Week3_3.00_self-report_psil_psil_25mg_1mg,-0.44711245099768004,0.16110623149156075,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,qids-sr,self-report,depression,0,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,75,-5.2,5.964970893413226,79,-3.6,6.121970644579615,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_qids-sr_Week3_3.00_self-report_psil_psil_10mg_1mg,-0.2633278511656256,0.16192262998463497,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,qids-sr,self-report,depression,0,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,79,-6.5,29.249415301880383,75,-5.5,7.069595132934194,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_qids-sr_Week12_12.00_self-report_psil_psil_25mg_10mg,-0.04622662928049439,0.1612407152803608,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,qids-sr,self-report,depression,0,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,79,-6.5,29.249415301880383,79,-5,7.028929258591409,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_qids-sr_Week12_12.00_self-report_psil_psil_25mg_1mg,-0.07017806878265766,0.15916090037279115,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,qids-sr,self-report,depression,0,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,75,-5.5,7.069595132934194,79,-5,7.028929258591409,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_qids-sr_Week12_12.00_self-report_psil_psil_10mg_1mg,-0.07058391584933107,0.16126964339145083,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,79,-15.026,12.05239162987994,75,-11.986,12.23693895547412,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Day2_0.29_clinician_psil_psil_25mg_10mg,-0.24912114593171114,0.16184889762185697,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,79,-15.026,12.05239162987994,79,-9.078,12.05239162987994,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Day2_0.29_clinician_psil_psil_25mg_1mg,-0.4911355461392626,0.16151531359867471,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,75,-11.986,12.23693895547412,79,-9.078,12.05239162987994,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Day2_0.29_clinician_psil_psil_10mg_1mg,-0.23830404354257123,0.16179547765251326,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,79,-13.043,11.128019410479116,75,-8.796,11.777945491468367,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week1_1.00_clinician_psil_psil_25mg_10mg,-0.3691147703716334,0.1625986548981942,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,79,-13.043,11.128019410479116,79,-6.887,11.590205520179529,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week1_1.00_clinician_psil_psil_25mg_1mg,-0.5392224906152644,0.16200466391463328,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,75,-8.796,11.777945491468367,79,-6.887,11.590205520179529,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week1_1.00_clinician_psil_psil_10mg_1mg,-0.1626064012693361,0.1614876557873197,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,79,-12,12.017201635656278,75,-7.9,11.92994178682645,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week3_3.00_clinician_psil_psil_25mg_10mg,-0.3406935104430146,0.16239510909666044,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,79,-12,12.017201635656278,79,-5.4,12.243941289159228,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week3_3.00_clinician_psil_psil_25mg_1mg,-0.5414362786523836,0.16202825463037127,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,75,-7.9,11.92994178682645,79,-5.4,12.243941289159228,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week3_3.00_clinician_psil_psil_10mg_1mg,-0.20572488372314504,0.16164882009978868,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,79,-11.53,13.447838153398484,75,-5.991,13.587938585377843,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week6_6.00_clinician_psil_psil_25mg_10mg,-0.40777834306524813,0.16290125228521177,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,79,-11.53,13.447838153398484,79,-6.261,12.985652043698076,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week6_6.00_clinician_psil_psil_25mg_1mg,-0.396680590448086,0.16068368535977462,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,75,-5.991,13.587938585377843,79,-6.261,12.985652043698076,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week6_6.00_clinician_psil_psil_10mg_1mg,0.020227364551533605,0.1612231460033115,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,79,-9.339,14.372210372799309,75,-6.109,14.497265259351504,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week9_9.00_clinician_psil_psil_25mg_10mg,-0.2226831246411134,0.16172248993252167,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,79,-9.339,14.372210372799309,79,-5.322,14.381098567216624,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week9_9.00_clinician_psil_psil_25mg_1mg,-0.27806582665982427,0.15988594311061494,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,75,-6.109,14.497265259351504,79,-5.322,14.381098567216624,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week9_9.00_clinician_psil_psil_10mg_1mg,-0.05424039656402192,0.16124890176260692,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,change,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,79,-9.496,14.381098567216624,75,-5.651,14.046932049383598,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week12_12.00_clinician_psil_psil_25mg_10mg,-0.26906891465809013,0.16195357576964794,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,79,-9.496,14.381098567216624,79,-6,14.843284676917031,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week12_12.00_clinician_psil_psil_25mg_1mg,-0.23807040049667147,0.15967953800211737,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,change,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,75,-5.651,14.046932049383598,79,-6,14.843284676917031,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_change_madrs_Week12_12.00_clinician_psil_psil_10mg_1mg,0.024014490416429342,0.1612248498722008,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,42,79,24,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Day2_0.29_clinician_psil_psil_25mg_10mg,-0.4830587546170357,0.18460139785622348,0.5076560490047115,0.1987073961752704,42,24,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,42,79,18,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Day2_0.29_clinician_psil_psil_25mg_1mg,-0.7392031664614711,0.1931898845207472,0.8472978603872034,0.23248359870940752,42,18,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,75,18,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Day2_0.29_clinician_psil_psil_10mg_1mg,-0.2560501307369524,0.2012339199868951,0.3396418113824921,0.2668907286527346,24,18,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35,79,17,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week1_1.00_clinician_psil_psil_25mg_10mg,-0.5477197428024279,0.19675846909551062,0.6701749785024865,0.24779708796061078,35,17,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35,79,12,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week1_1.00_clinician_psil_psil_25mg_1mg,-0.8180424576728349,0.21321350973168415,1.0704414117014134,0.2942589101600143,35,12,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,75,12,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week1_1.00_clinician_psil_psil_10mg_1mg,-0.2702183782652937,0.23019127933854724,0.40026643319892674,0.34083031197894276,17,12,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,29,79,14,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week3_3.00_clinician_psil_psil_25mg_10mg,-0.5086049686995625,0.20797947979381748,0.6762787614405044,0.28270084695279296,29,14,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,29,79,14,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week3_3.00_clinician_psil_psil_25mg_1mg,-0.5435180023226073,0.20724096435229838,0.7282385003712155,0.2838923640273872,29,14,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,75,14,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week3_3.00_clinician_psil_psil_10mg_1mg,-0.03484371103147465,0.2303969092060247,0.051959738930711166,0.34185608328024275,14,14,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,79,11,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week6_6.00_clinician_psil_psil_25mg_10mg,-0.5753717679377931,0.22317828682611393,0.8082415262924004,0.3215261547513589,26,11,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,79,16,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week6_6.00_clinician_psil_psil_25mg_1mg,-0.361219886716389,0.20309753160674246,0.4855078157817008,0.2750365116949674,26,16,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,75,16,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week6_6.00_clinician_psil_psil_10mg_1mg,0.21419795273801784,0.23707598100425442,-0.32273371051069955,0.3569559212671171,11,16,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,79,12,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week9_9.00_clinician_psil_psil_25mg_10mg,-0.3162279356450976,0.2247336563970807,0.4588658848352796,0.3276305421536563,20,12,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,79,12,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week9_9.00_clinician_psil_psil_25mg_1mg,-0.35004349052636913,0.2240918728239368,0.5108256237659907,0.3286592120071044,20,12,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,75,12,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week9_9.00_clinician_psil_psil_10mg_1mg,-0.03377090884963717,0.2449942438235493,0.05195973893071096,0.3750668013637465,12,12,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,79,12,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week12_12.00_clinician_psil_psil_25mg_10mg,-0.5189973626453196,0.21813111039555513,0.7212301493027706,0.30952109881789514,26,12,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,79,13,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week12_12.00_clinician_psil_psil_25mg_1mg,-0.5006705359745631,0.21310416959853204,0.6931471805599453,0.3001135779807586,26,13,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,75,13,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week12_12.00_clinician_psil_psil_10mg_1mg,0.018390684314713465,0.24112742302860626,-0.02808296874282525,0.36642168204812287,12,13,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,response,madrs,clinician,depression,1,Post-first dose 7,Week 3-12 Sustained Response,3,21,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,79,3,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week3-12SustainedResponse_3.00_clinician_psil_psil_25mg_10mg,-0.991606097434806,0.35967407444665267,1.6220166946409604,0.6081461766318182,16,3,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 7,Week 3-12 Sustained Response,3,21,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,79,6,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week3-12SustainedResponse_3.00_clinician_psil_psil_25mg_1mg,-0.6189887739448647,0.28044075360415094,0.9808292530117262,0.45149774193285186,16,6,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,response,madrs,clinician,depression,1,Post-first dose 7,Week 3-12 Sustained Response,3,21,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,75,6,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_response_madrs_Week3-12SustainedResponse_3.00_clinician_psil_psil_10mg_1mg,0.3726962719438642,0.4004589563337025,-0.6411874416292344,0.6884827077120859,3,6,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,remission,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,30,79,16,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Day2_0.29_clinician_psil_psil_25mg_10mg,-0.44674242736280145,0.20120910183979268,0.576648920491663,0.26427593941162847,30,16,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,30,79,15,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Day2_0.29_clinician_psil_psil_25mg_1mg,-0.5268422630656979,0.20334483851319313,0.6931471805599453,0.27328290159429564,30,15,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,75,15,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Day2_0.29_clinician_psil_psil_10mg_1mg,-0.08003264000584821,0.22172801748228335,0.1164982600682823,0.32120881912742066,16,15,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,remission,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25,79,8,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week1_1.00_clinician_psil_psil_25mg_10mg,-0.7434368468255194,0.2456007124716352,1.0874745442576539,0.37283835481152605,25,8,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25,79,9,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week1_1.00_clinician_psil_psil_25mg_1mg,-0.7029405493258104,0.23643933895710081,1.0216512475319814,0.35467542262596735,25,9,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,75,9,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week1_1.00_clinician_psil_psil_10mg_1mg,0.040585953519179874,0.2839864039092215,-0.06582329672567229,0.4583879906036768,8,9,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,remission,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23,79,7,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week3_3.00_clinician_psil_psil_25mg_10mg,-0.7591254001838817,0.2579479477568523,1.1376243279431253,0.40042957251590877,23,7,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23,79,6,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week3_3.00_clinician_psil_psil_25mg_1mg,-0.8827300822501518,0.2710501857493464,1.3437347467010947,0.4299168196756546,23,6,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,75,6,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week3_3.00_clinician_psil_psil_10mg_1mg,-0.12349209492711938,0.3204963224720413,0.20611041875796937,0.5324774627553498,7,6,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,remission,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,79,7,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week6_6.00_clinician_psil_psil_25mg_10mg,-0.6538221187633759,0.26123460485929806,0.9978623855679666,0.4084918379548216,20,7,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,79,10,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week6_6.00_clinician_psil_psil_25mg_1mg,-0.46621722690354056,0.23484404630530867,0.6931471805599453,0.35310557104610724,20,10,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,75,10,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week6_6.00_clinician_psil_psil_10mg_1mg,0.18766435518260557,0.2875674539727604,-0.3047152050080214,0.4656882881023617,7,10,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,remission,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,79,9,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week9_9.00_clinician_psil_psil_25mg_10mg,-0.3411681634517704,0.24940283965861199,0.5234044059728509,0.3842128966207101,16,9,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,79,9,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week9_9.00_clinician_psil_psil_25mg_1mg,-0.37349593678986254,0.24887467634175803,0.5753641449035619,0.3850904509526412,16,9,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,75,9,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week9_9.00_clinician_psil_psil_10mg_1mg,-0.03228013608197812,0.276577838141005,0.05195973893071096,0.4429793009168573,9,9,75,79
Goodwin 2022,psil,psil,25 mg,10 mg,remission,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,79,5,75,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week12_12.00_clinician_psil_psil_25mg_10mg,-0.8904593837321844,0.29129066636491696,1.3831247863586114,0.4707732856031797,21,5,79,75
Goodwin 2022,psil,psil,25 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,79,9,79,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week12_12.00_clinician_psil_psil_25mg_1mg,-0.5680696981905603,0.2404813298505602,0.8472978603872034,0.365258405836137,21,9,79,79
Goodwin 2022,psil,psil,10 mg,1 mg,remission,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,75,9,79,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_remission_madrs_Week12_12.00_clinician_psil_psil_10mg_1mg,0.3224621395606312,0.3213271089556729,-0.535826925971408,0.5339658696299573,5,9,75,79
Davis 2021,psil,wl,NA,NA,msd,bdi,self-report,depression,0,Post-second dose 1,Week 5,1,7,0,0,13,8.2,8.9,11,35.2,9.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,7,13,34.5,10,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_bdi_Week5_1.00_self-report_psil_wl_NA_NA,-2.8993026484422035,0.5963962469723182,NA,NA,NA,NA,NA,NA
Davis 2021,psil,wl,NA,NA,msd,bdi,self-report,depression,0,Post-second dose 2,Week 8,4,28,1,0,13,8.2,7,11,35.9,8.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,7,13,34.5,10,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_bdi_Week8_4.00_self-report_psil_wl_NA_NA,-3.4877965156076094,0.6630908327014231,NA,NA,NA,NA,NA,NA
Davis 2021,psil,wl,NA,NA,msd,qids-sr,self-report,depression,0,Post-second dose 1,Week 5,1,7,0,0,13,5.2,4.6,11,31.9,5.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16.2,3.6,13,17.4,3.6,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_qids-sr_Week5_1.00_self-report_psil_wl_NA_NA,-5.075654472752267,0.8623035336888092,NA,NA,NA,NA,NA,NA
Davis 2021,psil,wl,NA,NA,msd,qids-sr,self-report,depression,0,Post-second dose 2,Week 8,4,28,1,0,13,5.5,3.6,11,17.7,3.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16.2,3.6,13,17.4,3.6,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_qids-sr_Week8_4.00_self-report_psil_wl_NA_NA,-3.230930887290854,0.6333411754828401,NA,NA,NA,NA,NA,NA
Davis 2021,psil,wl,NA,NA,msd,grid-ham-d,clinician,depression,1,Post-second dose 1,Week 5,1,7,0,0,13,8,7.1,11,23.8,5.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22.9,3.6,13,22.5,4.4,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_grid-ham-d_Week5_1.00_clinician_psil_wl_NA_NA,-2.3897279858467972,0.543559686244671,NA,NA,NA,NA,NA,NA
Davis 2021,psil,wl,NA,NA,msd,grid-ham-d,clinician,depression,1,Post-second dose 2,Week 8,4,28,1,0,13,8.5,5.7,11,23.5,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22.9,3.6,13,22.5,4.4,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_grid-ham-d_Week8_4.00_clinician_psil_wl_NA_NA,-2.480657165357647,0.5525886095032462,NA,NA,NA,NA,NA,NA
Davis 2021,psil,wl,NA,NA,msd,phq-9,self-report,depression,0,Post-second dose 2,Week 8,4,28,1,0,13,4.8,2.9,11,18.8,4.3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16.5,3.1,13,17.9,3.3,11,Low,Some concerns,Some concerns,Low,Low,Some concerns,2021,psilocybin,waitlist,1st dose: 20 mg/70 kg; 2nd dose 30mg/70kg,NA,immediate treatment group,delayed treatment group,2,39.86666666666667,66.77777777777777,dep,NA,crossover,open-label,10.1001/jamapsychiatry.2020.3285; 10.1177/02698811211073759,NCT03181529,Davis2021_msd_phq-9_Week8_4.00_self-report_psil_wl_NA_NA,-3.750188537766883,0.6943576480171362,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,bdi,self-report,depression,0,Post-first dose 1,5 weeks after session 1,5,35,1,0,26,7,7.08763712389397,25,12.92,7.9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17.77,8.209421416884384,26,18.4,5.45,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_bdi_5weeksaftersession1_5.00_self-report_psil_psil_22mg/kg_1mg/kg,-0.7775488036740661,0.29081865281518515,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,bdi,self-report,depression,0,Post-second dose 1,5 weeks after session 2,5,35,0,1,25,5.8,7.05,24,8.17,6.0747345621022815,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17.77,8.209421416884384,26,18.4,5.45,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_bdi_5weeksaftersession2_5.00_self-report_psil_psil_22mg/kg_1mg/kg,-0.3538233957564135,0.288073118615127,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,bdi,self-report,depression,0,Follow-up 1,6 months,NA,NA,0,1,24,6.17,6.172714151813608,22,8,7.035623639735144,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17.77,8.209421416884384,26,18.4,5.45,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_bdi_6months_NA_self-report_psil_psil_22mg/kg_1mg/kg,-0.2725752914675986,0.29657580549376433,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,grid-ham-d,clinician,depression,1,Post-first dose 1,5 weeks after session 1,5,35,1,0,25,6.64,5.2,25,14.8,7.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_grid-ham-d_5weeksaftersession1_5.00_clinician_psil_psil_22mg/kg_1mg/kg,-1.273111041972242,0.311013705206831,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,grid-ham-d,clinician,depression,1,Post-second dose 1,5 weeks after session 2,5,35,0,1,25,6.52,7.199999999999999,24,6.5,4.213122357587066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_grid-ham-d_5weeksaftersession2_5.00_clinician_psil_psil_22mg/kg_1mg/kg,0.003318906554759989,0.28577400644764517,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,grid-ham-d,clinician,depression,1,Follow-up 1,6 months,NA,NA,0,1,24,6.23,6.368673331236263,22,6.95,5.816115542181053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_grid-ham-d_6months_NA_clinician_psil_psil_22mg/kg_1mg/kg,-0.11579698553577734,0.2954184999440294,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,hads-d,self-report,depression,0,Post-first dose 1,5 weeks after session 1,5,35,1,0,26,3.92,3.773274440058661,25,6.04,3.95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9.81,3.518323464379021,26,9.48,3.55,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_hads-d_5weeksaftersession1_5.00_self-report_psil_psil_22mg/kg_1mg/kg,-0.540654890825001,0.28533761588901346,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,hads-d,self-report,depression,0,Post-second dose 1,5 weeks after session 2,5,35,0,1,25,4.28,4.45,24,4.57,3.5762550244634395,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9.81,3.518323464379021,26,9.48,3.55,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_hads-d_5weeksaftersession2_5.00_self-report_psil_psil_22mg/kg_1mg/kg,-0.07052468938737315,0.2858655059501516,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,msd,hads-d,self-report,depression,0,Follow-up 1,6 months,NA,NA,0,1,24,3.46,3.233326460473795,22,4.64,3.3770993470728694,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9.81,3.518323464379021,26,9.48,3.55,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_msd_hads-d_6months_NA_self-report_psil_psil_22mg/kg_1mg/kg,-0.351155795867404,0.2975041276067579,NA,NA,NA,NA,NA,NA
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,response,grid-ham-d,clinician,depression,1,Post-first dose 1,5 weeks after session 1,5,35,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23,25,8,25,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_response_grid-ham-d_5weeksaftersession1_5.00_clinician_psil_psil_22mg/kg_1mg/kg,-1.7344355061193633,0.4701842561905779,1.0560526742493137,0.2974529557250444,23,8,25,25
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,response,grid-ham-d,clinician,depression,1,Post-second dose 1,5 weeks after session 2,5,35,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,25,18,24,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_response_grid-ham-d_5weeksaftersession2_5.00_clinician_psil_psil_22mg/kg_1mg/kg,-0.30358263731036345,0.39750823676920216,0.11332868530700307,0.14665584375651894,21,18,25,24
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,response,grid-ham-d,clinician,depression,1,Follow-up 1,6 months,NA,NA,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,24,17,22,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_response_grid-ham-d_6months_NA_clinician_psil_psil_22mg/kg_1mg/kg,-0.0602706738642289,0.3942888672998548,0.02421425812059453,0.15599325702709396,19,17,24,22
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,remission,grid-ham-d,clinician,depression,1,Post-first dose 1,5 weeks after session 1,5,35,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,25,4,25,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_remission_grid-ham-d_5weeksaftersession1_5.00_clinician_psil_psil_22mg/kg_1mg/kg,-1.1199028931681523,0.37566731872625075,1.3217558399823195,0.4864839839775475,15,4,25,25
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,remission,grid-ham-d,clinician,depression,1,Post-second dose 1,5 weeks after session 2,5,35,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,25,14,24,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_remission_grid-ham-d_5weeksaftersession2_5.00_clinician_psil_psil_22mg/kg_1mg/kg,-0.22637835717215685,0.32860871876094516,0.15333401992070234,0.22042103840983385,17,14,25,24
Griffiths 2016,psil,psil,22 mg/kg,1 mg/kg,remission,grid-ham-d,clinician,depression,1,Follow-up 1,6 months,NA,NA,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,24,13,22,22.84,4.946048928185001,26,22.32,4.4,25,Low,Low,Low,Some concerns,High,High,2016,psilocybin,psilocybin,22 mg/kg,1 mg/kg,High-Dose-1st Group,Low-Dose-1st Group,1,56.30714285714286,49.035714285714285,cancer,NA,crossover,double-blind,10.1177/0269881116675513,NCT00465595,Griffiths2016_remission_grid-ham-d_6months_NA_clinician_psil_psil_22mg/kg_1mg/kg,-0.28154787481164734,0.3441788964866293,0.18125260960504955,0.22051166457498236,17,13,24,22
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Pre-first dose 1,1 day pre-dose 1,-0.14,-1,0,0,14,10.4,6.907099535984696,15,16.247,7.544571558412048,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_1daypre-dose1_-0.14_self-report_psil_ncn_NA_NA,-0.7844504041534085,0.3864270455432182,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,14,4.188,6.907099535984696,15,12.034,6.952005106442313,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.1003688726146175,0.4002412526999355,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 2,2 weeks post-dose 1,2,14,0,0,14,6.636,7.154048923511776,14,13.449,7.520731347415621,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_2weekspost-dose1_2.00_self-report_psil_ncn_NA_NA,-0.9012058794502611,0.39779825545069464,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 3,6 weeks post-dose 1,6,42,0,0,14,6.438,6.716275009259224,14,14.181,6.907099535984696,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_6weekspost-dose1_6.00_self-report_psil_ncn_NA_NA,-1.1035060876199028,0.4073407922922575,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,12,7.097,6.394731581544295,14,12.841,7.483314773547883,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-0.7940449465871926,0.4095005613478123,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-second dose 2,6 weeks post-dose 2,6,42,0,1,12,6.212,6.574864865531458,11,9.545,6.80571406980928,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_6weekspost-dose2_6.00_self-report_psil_ncn_NA_NA,-0.4805013996050981,0.42384559091222324,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,11,6.41,6.460785091612319,12,8.974,6.928203230275509,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_bdi_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.3683220830553002,0.42120887187393813,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Pre-first dose 1,1 day pre-dose 1,-0.14,-1,0,0,14,3.859,3.4797413696997657,15,5.945,3.40435236131632,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_1daypre-dose1_-0.14_self-report_psil_ncn_NA_NA,-0.589246817928049,0.3800421026547544,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,14,2.019,3.382458277643643,15,6.164,3.2107031940059487,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.2228754027737028,0.4066784479091278,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Post-first dose 2,2 weeks post-dose 1,2,14,0,0,14,2.109,3.4348414810584784,14,5.831,3.4348414810584784,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_2weekspost-dose1_2.00_self-report_psil_ncn_NA_NA,-1.0520404661865639,0.4047528478959177,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Post-first dose 3,6 weeks post-dose 1,6,42,0,0,14,2.263,3.4797413696997657,14,6.761,3.101833973635597,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_6weekspost-dose1_6.00_self-report_psil_ncn_NA_NA,-1.3248527784921769,0.41965395372589337,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,12,2.734,3.308217042456555,14,6.101,3.2889168429742943,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-0.9887490551503767,0.41810105073795906,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Post-second dose 2,6 weeks post-dose 2,6,42,0,1,12,1.791,3.308217042456555,11,4.906,3.1673766747894065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_6weekspost-dose2_6.00_self-report_psil_ncn_NA_NA,-0.9261227195559422,0.4408092533097004,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,msd,hads-d,self-report,depression,0,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,11,1.96,3.3332079143071764,12,4.271,3.308217042456555,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_msd_hads-d_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.6708961862288095,0.4298544695668993,NA,NA,NA,NA,NA,NA
Ross 2016,psil,ncn,NA,NA,response,bdi,self-report,depression,1,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,14,4,15,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_response_bdi_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.5022397435190566,0.5300339698454415,1.167605160155061,0.44185755084426837,12,4,14,15
Ross 2016,psil,ncn,NA,NA,response,bdi,self-report,depression,1,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,12,2,14,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_response_bdi_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-1.8159622356840257,0.5997417793770075,1.7635885922613588,0.6672616392676078,10,2,12,14
Ross 2016,psil,ncn,NA,NA,response,bdi,self-report,depression,1,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,11,7,12,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_response_bdi_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.6204669525176622,0.5384900908538924,0.33832580527053585,0.28235762735550407,9,7,11,12
Ross 2016,psil,ncn,NA,NA,remission,hads-d,self-report,depression,0,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,14,3,15,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_remission_hads-d_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.4391232214762775,0.5055746367051397,1.3682758556172123,0.5349272718297191,11,3,14,15
Ross 2016,psil,ncn,NA,NA,remission,hads-d,self-report,depression,0,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,12,6,14,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_remission_hads-d_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-0.5236828925973784,0.45015815807855303,0.44183275227903923,0.3700064349504774,8,6,12,14
Ross 2016,psil,ncn,NA,NA,remission,hads-d,self-report,depression,0,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,11,7,12,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_remission_hads-d_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.6204669525176622,0.5384900908538924,0.33832580527053585,0.28235762735550407,9,7,11,12
Ross 2016,psil,ncn,NA,NA,response,hads-d,self-report,depression,0,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,14,3,15,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_response_hads-d_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.4391232214762775,0.5055746367051397,1.3682758556172123,0.5349272718297191,11,3,14,15
Ross 2016,psil,ncn,NA,NA,response,hads-d,self-report,depression,0,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,12,6,14,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_response_hads-d_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-0.5236828925973784,0.45015815807855303,0.44183275227903923,0.3700064349504774,8,6,12,14
Ross 2016,psil,ncn,NA,NA,response,hads-d,self-report,depression,0,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,11,7,12,5.298,3.4797413696997657,14,7.007,3.501176944971505,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_response_hads-d_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.6204669525176622,0.5384900908538924,0.33832580527053585,0.28235762735550407,9,7,11,12
Ross 2016,psil,ncn,NA,NA,remission,bdi,self-report,depression,1,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,14,4,15,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_remission_bdi_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.5022397435190566,0.5300339698454415,1.167605160155061,0.44185755084426837,12,4,14,15
Ross 2016,psil,ncn,NA,NA,remission,bdi,self-report,depression,1,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,12,2,14,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_remission_bdi_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-1.8159622356840257,0.5997417793770075,1.7635885922613588,0.6672616392676078,10,2,12,14
Ross 2016,psil,ncn,NA,NA,remission,bdi,self-report,depression,1,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,11,7,12,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_remission_bdi_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.6204669525176622,0.5384900908538924,0.33832580527053585,0.28235762735550407,9,7,11,12
Ross 2016,psil,ncn,NA,NA,unknown,bdi,self-report,depression,0,Post-first dose 1,1 day post-dose 1,0.14,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,14,3,15,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_unknown_bdi_1daypost-dose1_0.14_self-report_psil_ncn_NA_NA,-1.4391232214762775,0.5055746367051397,1.3682758556172123,0.5349272718297191,11,3,14,15
Ross 2016,psil,ncn,NA,NA,unknown,bdi,self-report,depression,0,Post-first dose 4,7 weeks post-dose 1 and 1 day pre-dose 2,7,49,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,12,3,14,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_unknown_bdi_7weekspost-dose1and1daypre-dose2_7.00_self-report_psil_ncn_NA_NA,-1.2802806693915132,0.5138571253273897,1.252762968495368,0.5382216454979674,9,3,12,14
Ross 2016,psil,ncn,NA,NA,unknown,bdi,self-report,depression,0,Post-second dose 3,26 weeks post-dose 2,26,182,0,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,11,7,12,15.176,7.097924062710167,14,16.92,6.952005106442313,15,Low,Low,Low,Some concerns,Some concerns,Some concerns,2016,psilocybin,niacin,0.3 mg/kg,250 mg,Psilocybin 1st group,Niacin 1st group,1,56.00161290322581,61.12903225806452,cancer,NA,crossover,double-blind,10.1177/0269881116675512,NCT00957359,Ross2016_unknown_bdi_26weekspost-dose2_26.00_self-report_psil_ncn_NA_NA,-0.6204669525176622,0.5384900908538924,0.33832580527053585,0.28235762735550407,9,7,11,12
Grob 2011,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Pre-first dose 1,1 day before experimental session,-0.14,-1,0,1,12,16.09,12.70978882594042,12,14.369,13.648560363642751,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Some concerns,Low,Some concerns,High,High,2011,psilocybin,niacin,0.2 mg/kg,250 mg,psilocybin,niacin placebo,1,NA,NA,cancer,NA,crossover,double-blind,10.1001/archgenpsychiatry.2010.116,NCT00302744,Grob2011_msd_bdi_1daybeforeexperimentalsession_-0.14_self-report_psil_ncn_NA_NA,0.12600199461443884,0.4086826088480137,NA,NA,NA,NA,NA,NA
Grob 2011,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 1,1 day after experimental session,0.14,1,0,1,12,11.442,10.04243058228435,12,13.208,11.767553186622951,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Some concerns,Low,Some concerns,High,High,2011,psilocybin,niacin,0.2 mg/kg,250 mg,psilocybin,niacin placebo,1,NA,NA,cancer,NA,crossover,double-blind,10.1001/archgenpsychiatry.2010.116,NCT00302744,Grob2011_msd_bdi_1dayafterexperimentalsession_0.14_self-report_psil_ncn_NA_NA,-0.15587305359912776,0.4089127570187873,NA,NA,NA,NA,NA,NA
Grob 2011,psil,ncn,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 2,2 weeks after experimental session,2,14,1,1,12,10.054,9.25607951564808,12,13.27,10.981202119986682,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Some concerns,Low,Some concerns,High,High,2011,psilocybin,niacin,0.2 mg/kg,250 mg,psilocybin,niacin placebo,1,NA,NA,cancer,NA,crossover,double-blind,10.1001/archgenpsychiatry.2010.116,NCT00302744,Grob2011_msd_bdi_2weeksafterexperimentalsession_2.00_self-report_psil_ncn_NA_NA,-0.30576069806097955,0.4107991875680299,NA,NA,NA,NA,NA,NA
Krempien 2023,psil-d,psil-d,16 mg,12 mg,msd,madrs,clinician,depression,1,Post-first dose 4,Day 21,3,21,1,NA,9,16.556,6.146,15,15.867,8.684,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.444,4.035,9,32.611,3.664,18,Low,Some concerns,Low,Some concerns,High,High,2023,CYB003 deuterated psilocin,CYB003 deuterated psilocin,16 mg,12 mg,16 mg group,12 mg group,1,NA,NA,dep,NA,parallel,double-blind,10.1038/s41386-023-01755-5,NCT05385783,Krempien2023_msd_madrs_Day21_3.00_clinician_psil-d_psil-d_16mg_12mg,0.08467365452156889,0.4218269842380592,NA,NA,NA,NA,NA,NA
Krempien 2023,psil-d,pcb,16 mg,NA,msd,madrs,clinician,depression,1,Post-first dose 4,Day 21,3,21,1,NA,9,16.556,6.146,9,29,5.315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.444,4.035,9,31.556,4.927,9,Low,Some concerns,Low,Some concerns,High,High,2023,CYB003 deuterated psilocin,placebo,16 mg,NA,16 mg group,placebo,1,NA,NA,dep,NA,parallel,double-blind,10.1038/s41386-023-01755-5,NCT05385783,Krempien2023_msd_madrs_Day21_3.00_clinician_psil-d_pcb_16mg_NA,-2.062716695381685,0.5937385597110831,NA,NA,NA,NA,NA,NA
Krempien 2023,psil-d,pcb,12 mg,NA,msd,madrs,clinician,depression,1,Post-first dose 4,Day 21,3,21,1,NA,15,15.867,8.684,9,29,5.315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,32.611,3.664,18,31.556,4.927,9,Low,Some concerns,Low,Some concerns,High,High,2023,CYB003 deuterated psilocin,placebo,12 mg,NA,12 mg group,placebo,1,NA,NA,dep,NA,parallel,double-blind,10.1038/s41386-023-01755-5,NCT05385783,Krempien2023_msd_madrs_Day21_3.00_clinician_psil-d_pcb_12mg_NA,-1.6612385381643295,0.48933818503919907,NA,NA,NA,NA,NA,NA
Back 2024,psil,ncn,NA,NA,msd,madrs,clinician,depression,1,Pre-first dose 1,Day -8,1.14,8,0,NA,15,27.67,5.27,15,28.4,7.39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2024,psilocybin,niacin,25 mg,100 mg,psilocybin arm,niacin arm,1,38,50,dep,NA,parallel,double-blind,10.1001/jamanetworkopen.2024.49026,NCT05163496,Back2024_msd_madrs_Day-8_1.14_clinician_psil_ncn_NA_NA,-0.11066608890309594,0.3654434936033943,NA,NA,NA,NA,NA,NA
Back 2024,psil,ncn,NA,NA,msd,madrs,clinician,depression,1,Post-first dose 4,Day 28,4,28,1,NA,15,6.33,6.72,15,19.07,10.34,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Low,Low,Low,Low,Low,Low,2024,psilocybin,niacin,25 mg,100 mg,psilocybin arm,niacin arm,1,38,50,dep,NA,parallel,double-blind,10.1001/jamanetworkopen.2024.49026,NCT05163496,Back2024_msd_madrs_Day28_4.00_clinician_psil_ncn_NA_NA,-1.42153552640956,0.4109863564018378,NA,NA,NA,NA,NA,NA
Rieser 2025,psil,pcb,NA,NA,msd,bdi,self-report,depression,1,Flexible Timepoint 1,Day -14,2,14,0,NA,18,12.72,8.37,19,12.21,7.75,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06,8.99,18,11.05,8.02,19,Low,Low,Some concerns,Some concerns,Low,Some concerns,2025,psilocybin,mannitol,25 mg,100% mannitol,psilocybin,placebo,1,37.2675,37.7975,aud,NA,parallel,double-blind,10.1016/j.eclinm.2025.103149,NCT04141501,Rieser2025_msd_bdi_Day-14_2.00_self-report_psil_pcb_NA_NA,0.06193203084870311,0.3290004233265356,NA,NA,NA,NA,NA,NA
Rieser 2025,psil,pcb,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 1,Day 1,0.14,1,0,NA,18,6.11,5.61,19,8.61,10.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06,8.99,18,11.05,8.02,19,Low,Low,Some concerns,Some concerns,Low,Some concerns,2025,psilocybin,mannitol,25 mg,100% mannitol,psilocybin,placebo,1,37.2675,37.7975,aud,NA,parallel,double-blind,10.1016/j.eclinm.2025.103149,NCT04141501,Rieser2025_msd_bdi_Day1_0.14_self-report_psil_pcb_NA_NA,-0.2819325833110539,0.33061938896167,NA,NA,NA,NA,NA,NA
Rieser 2025,psil,pcb,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 2,Day 14,2,14,0,NA,18,7.17,7.13,18,10.79,10.97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06,8.99,18,11.05,8.02,19,Low,Low,Some concerns,Some concerns,Low,Some concerns,2025,psilocybin,mannitol,25 mg,100% mannitol,psilocybin,placebo,1,37.2675,37.7975,aud,NA,parallel,double-blind,10.1016/j.eclinm.2025.103149,NCT04141501,Rieser2025_msd_bdi_Day14_2.00_self-report_psil_pcb_NA_NA,-0.38259563495698945,0.336507979084192,NA,NA,NA,NA,NA,NA
Rieser 2025,psil,pcb,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 3,Day 30,4.29,30,1,NA,18,7.17,7.13,19,10.79,10.97,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06,8.99,18,11.05,8.02,19,Low,Low,Some concerns,Some concerns,Low,Some concerns,2025,psilocybin,mannitol,25 mg,100% mannitol,psilocybin,placebo,1,37.2675,37.7975,aud,NA,parallel,double-blind,10.1016/j.eclinm.2025.103149,NCT04141501,Rieser2025_msd_bdi_Day30_4.29_self-report_psil_pcb_NA_NA,-0.38064430600023824,0.3320127145271995,NA,NA,NA,NA,NA,NA
Rieser 2025,psil,pcb,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 4,Day 96,13.71,96,0,NA,17,7.76,7.97,18,14,12.77,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06,8.99,18,11.05,8.02,19,Low,Low,Some concerns,Some concerns,Low,Some concerns,2025,psilocybin,mannitol,25 mg,100% mannitol,psilocybin,placebo,1,37.2675,37.7975,aud,NA,parallel,double-blind,10.1016/j.eclinm.2025.103149,NCT04141501,Rieser2025_msd_bdi_Day96_13.71_self-report_psil_pcb_NA_NA,-0.5690394338020737,0.3452886597225526,NA,NA,NA,NA,NA,NA
Rieser 2025,psil,pcb,NA,NA,msd,bdi,self-report,depression,1,Post-first dose 5,Day 190,27.14,190,0,NA,17,9.47,10.26,17,11.41,9.68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13.06,8.99,18,11.05,8.02,19,Low,Low,Some concerns,Some concerns,Low,Some concerns,2025,psilocybin,mannitol,25 mg,100% mannitol,psilocybin,placebo,1,37.2675,37.7975,aud,NA,parallel,double-blind,10.1016/j.eclinm.2025.103149,NCT04141501,Rieser2025_msd_bdi_Day190_27.14_self-report_psil_pcb_NA_NA,-0.1899069644956147,0.34380720548107796,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,imsd,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,79,16.874,12.6335,75,21.014,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Day2_0.29_clinician_psil_psil_25mg_10mg,-0.35243202924914263,0.16247723218096186,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,79,16.874,12.6335,79,23.622000000000003,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Day2_0.29_clinician_psil_psil_25mg_1mg,-0.5758304553919306,0.1624067144343914,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,75,21.014,12.6335,79,23.622000000000003,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Day2_0.29_clinician_psil_psil_10mg_1mg,-0.22303109008987446,0.16172406225951358,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,imsd,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,79,18.857,12.6335,75,24.204,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week1_1.00_clinician_psil_psil_25mg_10mg,-0.45518214019206904,0.1633124537224988,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,79,18.857,12.6335,79,25.813000000000002,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week1_1.00_clinician_psil_psil_25mg_1mg,-0.5935798233115395,0.1626107701225832,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 2,Week 1,1,7,0,NA,75,24.204,12.6335,79,25.813000000000002,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week1_1.00_clinician_psil_psil_10mg_1mg,-0.13759855212983427,0.1614114162615676,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,imsd,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,79,19.9,12.6335,75,25.1,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week3_3.00_clinician_psil_psil_25mg_10mg,-0.4426682492984402,0.16319961714977405,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,79,19.9,12.6335,79,27.300000000000004,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week3_3.00_clinician_psil_psil_25mg_1mg,-0.6314678971399359,0.16306615036334346,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 3,Week 3,3,21,1,NA,75,25.1,12.6335,79,27.300000000000004,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week3_3.00_clinician_psil_psil_10mg_1mg,-0.1881397232353235,0.1615785552786152,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,imsd,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,79,20.369999999999997,12.6335,75,27.009,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week6_6.00_clinician_psil_psil_25mg_10mg,-0.5651681744408354,0.16443524745559746,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,79,20.369999999999997,12.6335,79,26.439000000000004,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week6_6.00_clinician_psil_psil_25mg_1mg,-0.5178890091543611,0.16178211316838528,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 4,Week 6,6,42,0,NA,75,27.009,12.6335,79,26.439000000000004,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week6_6.00_clinician_psil_psil_10mg_1mg,0.04874529192915165,0.16124314754052163,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,imsd,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,79,22.561,12.6335,75,26.891,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week9_9.00_clinician_psil_psil_25mg_10mg,-0.3686064460504316,0.16259487357274882,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,79,22.561,12.6335,79,27.378000000000004,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week9_9.00_clinician_psil_psil_25mg_1mg,-0.4110514676382528,0.16079905686677845,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 5,Week 9,9,63,0,NA,75,26.891,12.6335,79,27.378000000000004,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week9_9.00_clinician_psil_psil_10mg_1mg,-0.041647293279819746,0.16123662346422468,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,10 mg,imsd,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,79,22.403999999999996,12.6335,75,27.349,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,33,6.31,75,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,10 mg,25-mg group,10-mg group,1,40.394805194805194,55.51298701298701,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week12_12.00_clinician_psil_psil_25mg_10mg,-0.4209604793809207,0.1630111668793877,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,25 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,79,22.403999999999996,12.6335,79,26.700000000000003,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31.9,5.41,79,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,25 mg,1 mg,25-mg group,1-mg group,1,39.45,51,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week12_12.00_clinician_psil_psil_25mg_1mg,-0.3665927143396171,0.16045518633016942,NA,NA,NA,NA,NA,NA
Goodwin 2022,psil,psil,10 mg,1 mg,imsd,madrs,clinician,depression,1,Post-first dose 6,Week 12,12,84,0,NA,75,27.349,12.6335,79,26.700000000000003,10.6025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,6.31,75,32.7,6.24,79,Low,Low,Low,Low,Low,Low,2022,psilocybin,psilocybin,10 mg,1 mg,10-mg group,1-mg group,1,39.62532467532468,50.38311688311688,trd,NA,parallel,double-blind,10.1056/NEJMoa2206443; https://doi.org/10.1016/j.jad.2023.01.108,NCT03775200,Goodwin2022_imsd_madrs_Week12_12.00_clinician_psil_psil_10mg_1mg,0.05550121835442013,0.1612503086171119,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,imsd,madrs,clinician,depression,1,Post-first dose 1,Day 2,0.29,2,0,NA,51,32.8,13.04,53,32.3,12.51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_imsd_madrs_Day2_0.29_clinician_psil_ncn_NA_NA,0.038857895257810034,0.19617118846853163,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,imsd,madrs,clinician,depression,1,Post-first dose 2,Day 8,1.14,8,0,NA,51,17.7,13.04,53,29.2,12.51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_imsd_madrs_Day8_1.14_clinician_psil_ncn_NA_NA,-0.8937315909296307,0.2058474812418711,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,imsd,madrs,clinician,depression,1,Post-first dose 3,Day 15,2.14,15,0,NA,51,17.5,13.04,53,28.1,12.51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_imsd_madrs_Day15_2.14_clinician_psil_ncn_NA_NA,-0.8237873794655729,0.20441875078939495,NA,NA,NA,NA,NA,NA
Raison 2023,psil,ncn,NA,NA,imsd,madrs,clinician,depression,1,Post-first dose 4,Day 29,4.14,29,0,NA,51,16.3,13.04,53,29.5,12.51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35.5,5.7,51,35,4.5,53,Low,Low,Low,Low,Low,Some concerns,2023,psilocybin,niacin,25 mg,100 mg,psilocybin,niacin,1,41.11346153846153,50.05769230769231,dep,NA,parallel,double-blind,10.1001/jama.2023.14530; 10.1001/jama.2024.0828,NCT03866174,Raison2023_imsd_madrs_Day29_4.14_clinician_psil_ncn_NA_NA,-1.025848434806185,0.2088315927381016,NA,NA,NA,NA,NA,NA
Rosenblat 2024,psil,wl,NA,NA,imsd,madrs,clinician,depression,1,Post-first dose 1,Day 1,0.14,1,0,0,16,19.723,12.227,14,26.536,8.695,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,3.9,16,27.6,6.6,15,Some concerns,Low,Low,High,Low,High,2024,psilocybin,waitlist,25 mg,NA,immediate group,delayed group,1,44.126666666666665,39.13333333333333,trd,NA,crossover,open-label,10.1016/j.medj.2024.01.005,NCT05029466,Rosenblat2024_imsd_madrs_Day1_0.14_clinician_psil_wl_NA_NA,-0.6176336525961714,0.3750260615676323,NA,NA,NA,NA,NA,NA
Rosenblat 2024,psil,wl,NA,NA,imsd,madrs,clinician,depression,1,Post-first dose 2,Day 7,1,7,0,0,16,21.680999999999997,12.227,14,24.579,8.695,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,3.9,16,27.6,6.6,15,Some concerns,Low,Low,High,Low,High,2024,psilocybin,waitlist,25 mg,NA,immediate group,delayed group,1,44.126666666666665,39.13333333333333,trd,NA,crossover,open-label,10.1016/j.medj.2024.01.005,NCT05029466,Rosenblat2024_imsd_madrs_Day7_1.00_clinician_psil_wl_NA_NA,-0.26271867389163456,0.36761898640652363,NA,NA,NA,NA,NA,NA
